Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Tavazzi L. Swedberg K, et al. Among authors: tavazzi l. Eur J Heart Fail. 2010 Jan;12(1):75-81. doi: 10.1093/eurjhf/hfp154. Epub 2009 Nov 5. Eur J Heart Fail. 2010. PMID: 19892778 Free article. Clinical Trial.
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
Shibata MC, Flather MD, Böhm M, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Parkhomenko A, Soler-Soler J, Tavazzi L, Toman J, Van Veldhuisen DJ, Coats AJ, Poole-Wilson P; Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure. Shibata MC, et al. Among authors: tavazzi l. Int J Cardiol. 2002 Nov;86(1):77-85. doi: 10.1016/s0167-5273(02)00321-2. Int J Cardiol. 2002. PMID: 12243852 No abstract available.
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T. Mann DL, et al. Among authors: tavazzi l. Circulation. 2004 Apr 6;109(13):1594-602. doi: 10.1161/01.CIR.0000124490.27666.B2. Epub 2004 Mar 15. Circulation. 2004. PMID: 15023878 Clinical Trial.
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design.
Zile M, Gaasch W, Little W, Francis G, Tavazzi L, Cleland J, Davies M; MCC-135 GO1 Investigators. Zile M, et al. Among authors: tavazzi l. J Card Fail. 2004 Jun;10(3):193-9. doi: 10.1016/j.cardfail.2003.10.004. J Card Fail. 2004. PMID: 15190528 Clinical Trial.
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M; GISSI-HF Investigators. Tavazzi L, et al. Eur J Heart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. Eur J Heart Fail. 2004. PMID: 15302013 Free article. Clinical Trial.
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators. Flather MD, et al. Among authors: tavazzi l. Eur Heart J. 2005 Feb;26(3):215-25. doi: 10.1093/eurheartj/ehi115. Epub 2005 Jan 9. Eur Heart J. 2005. PMID: 15642700 Clinical Trial.
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Lévy S, Linde C, Lopez-Sendon JL, Nieminen MS, Piérard L, Remme WJ; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Swedberg K, et al. Among authors: tavazzi l. Eur Heart J. 2005 Jun;26(11):1115-40. doi: 10.1093/eurheartj/ehi204. Epub 2005 May 18. Eur Heart J. 2005. PMID: 15901669 Free article. No abstract available.
[Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)].
Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Lévy S, Linde C, López-Sendón JL, Nieminen MS, Piérard L, Remme WJ; Grupo de Trabajo de Diagnóstico y Tratamiento de la Insuficiencia Cardíaca Crónica de la Sociedad Europea de Cardiología; Comité de la ESC para la elaboración de las Guías de Práctica Clínica. Swedberg K, et al. Among authors: tavazzi l. Rev Esp Cardiol. 2005 Sep;58(9):1062-92. doi: 10.1157/13078554. Rev Esp Cardiol. 2005. PMID: 16185619 Free article. Spanish. No abstract available.
[Adherence to guidelines in CHF therapy in Germany].
Flesch M, Komajda M, Lapuerta P, Hermans N, Le Pen C, Gonzáles-Juanatey JR, Van Veldhuisen DJ, Tavazzi L, Poole-Wilson P, Erdmann E. Flesch M, et al. Among authors: tavazzi l. Dtsch Med Wochenschr. 2005 Sep 30;130(39):2191-7. doi: 10.1055/s-2005-916363. Dtsch Med Wochenschr. 2005. PMID: 16189755 German.
799 results